Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Clover Health Investments's revenue for the twelve months ending Sep 30, 2026 was $2.74B, up 54.5% year over year. For fiscal 2025 it was $1.92B, up 40.3% from the year before. The highest annual figure on record is $1.92B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.92B | +40.3% |
| FY2024 | Dec 31, 2024 | $1.37B | +8.8% |
| FY2023 | Dec 31, 2023 | $1.26B | +15.0% |
| FY2022 | Dec 31, 2022 | $1.10B | -25.5% |
| FY2021 | Dec 31, 2021 | $1.47B | +118.8% |
| FY2020 | Dec 31, 2020 | $672.89M | +45.6% |
| FY2019 | Dec 31, 2019 | $462.27M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $759.30M | +52.9% |
| Q2 FY2026 | Jun 30, 2026 | $743.17M | +55.6% |
| Q1 FY2026 | Mar 31, 2026 | $749.19M | +62.0% |
| Q4 FY2025 | Dec 31, 2025 | $487.71M | +44.7% |
| Q3 FY2025 | Sep 30, 2025 | $496.65M | +50.1% |
| Q2 FY2025 | Jun 30, 2025 | $477.62M | +34.1% |
| Q1 FY2025 | Mar 31, 2025 | $462.33M | +33.3% |
| Q4 FY2024 | Dec 31, 2024 | $336.96M | +7.9% |
| Q3 FY2024 | Sep 30, 2024 | $330.99M | +8.2% |
| Q2 FY2024 | Jun 30, 2024 | $356.26M | +11.3% |
| Q1 FY2024 | Mar 31, 2024 | $346.92M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $312.39M | -65.2% |
| Q3 FY2023 | Sep 30, 2023 | $306.03M | -64.3% |
| Q2 FY2023 | Jun 30, 2023 | $320.14M | -62.2% |
| Q1 FY2023 | Mar 31, 2023 | $321.99M | -63.2% |
| Q4 FY2022 | Dec 31, 2022 | $898.79M | +108.0% |
| Q3 FY2022 | Sep 30, 2022 | $856.82M | +100.6% |
| Q2 FY2022 | Jun 30, 2022 | $846.70M | +105.3% |
| Q1 FY2022 | Mar 31, 2022 | $874.38M | +336.5% |
| Q4 FY2021 | Dec 31, 2021 | $432.04M | +159.9% |
| Q3 FY2021 | Sep 30, 2021 | $427.16M | +152.7% |
| Q2 FY2021 | Jun 30, 2021 | $412.47M | +139.7% |
| Q1 FY2021 | Mar 31, 2021 | $200.33M | +21.0% |
| Q4 FY2020 | Dec 31, 2020 | $166.23M | – |
| Q3 FY2020 | Sep 30, 2020 | $169.07M | – |
| Q2 FY2020 | Jun 30, 2020 | $172.08M | – |
| Q1 FY2020 | Mar 31, 2020 | $165.51M | – |
See a number that looks wrong?